Xtx Topco LTD Galera Therapeutics, Inc. Transaction History

Xtx Topco LTD

$1.12 Billion
Q2 2024

A detailed history of Xtx Topco LTD transactions in Galera Therapeutics, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 52,113 shares of GRTX stock, worth $2,605. This represents 0.0% of its overall portfolio holdings.

Number of Shares

52,113

Previous 25,246 106.42%

Holding current value

$2,605

Previous $3,000 133.33%

% of portfolio

0.0%

Previous 0.0%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$0.08 - $0.23 $2,149 - $6,179	26,867 Added 106.42%	52,113 $7,000
Q1 2024 May 13, 2024	SELL	$0.14 - $0.27 $2,027 - $3,909	-14,480 Reduced 36.45%	25,246 $3,000
Q4 2023 Feb 13, 2024	BUY	$0.09 - $0.27 $3,575 - $10,726	39,726 New	39,726 $5,000
Q2 2023 Aug 14, 2023	BUY	$2.5 - $3.42 $133,730 - $182,942	53,492 New	53,492 $166,000
Q1 2022 May 13, 2022	SELL	$2.01 - $4.19 $27,132 - $56,560	-13,499 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$1.27 - $8.28 $17,143 - $111,771	13,499 New	13,499 $62,000

Others Institutions Holding GRTX

# of Institutions

Shares Held

961K

Call Options Held

Put Options Held

View Full List

About Galera Therapeutics, Inc.

Ticker GRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,821,600
Market Cap $1.34M
Description
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...

More about GRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Account